Emerging New Gadolinium Imaging Contrast Agent Litigation
Lawsuits related to Gadolinium Contrast Dyes have previously been consolidated in MDL 1909 on June 6th, 2008. The current issues related to Gadolinium Contrast Dyes are different from those litigated in MDL 1909.
MDL 1909 Defendants: General Electric Company, GE Healthcare, Inc., and GE Healthcare Bio-sciences Corp. (the GE defendants), and Mallinckrodt, Inc.
FDA December 2017 After reviewing available data, the FDA recommended that radiologists consider how much gadolinium might be left behind in a patient’s body when selecting a gadolinium-based contrast agent [GBCA] for an MRI.
The current primary concern related to Gadolinium Contrast Agents relates to the buildup in the brain, of certain substances contained in these agents.
Gena Norris, wife of actor Chuck Norris recently brought a lawsuit alleging that she fell ill after exposure to gadolinium used in an MRI.
Gadolinium Contrast Agents include:
Ablavar (gadofosveset trisodium)
Dotarem (gadoterate meglumine)
Eovist (gadoxetate disodium)
Magnevist (gadopentetate dimeglumine)
MultiHance (gadobenate dimeglumine)
To Learn More About the Emerging New Gadolinium Contrast Agent Litigation:
The emerging New Gadolinium Contrast Agent will be used as a case study in the May 18th to 21st 2018 Mass Tort Nexus, “Four Days to Mass Tort Success Course” To register for the May Course, contact Jenny Levine at firstname.lastname@example.org or call (954) 520-4494.
For information on the class and to enroll, use this link-“Enroll Here To Attend “Four Days to Mass Tort Success”
Course attendees will receive the benefit of a step by step analysis of the emerging New Gadolinium Contrast using these primary metrics:
See endorsements below of some of the top mass tort trial lawyers in the country who’ve attended the Mass Tort Nexus Immersion Course>
The Mass Tort Nexus Classes on Emerging Litigation and Ongoing Mass Torts are considered the premier source in the country to learn about the fundamentals of mass torts and how to enhance your firm practice, increase revenues and manage the related business operations effectively. Don’t wait for the next class or next year, enroll today and learn what others already have, Mass Torts are where your firm can and will grow its practice.